- Location
Bristol Myers
"-
Passion, Morale And Motivation
Mar 11, 2016Spun-off from ITT Corporation in October 2011, Xylem Inc. was formed from ITT's separate water businesses and now operates as a global water technology organization. The company was organized into the five areas of transport, treatment, ...
Tags: Xylem, ITT, Patrick Decker
-
EPA Announced a Settlement with Companies to Address The Pohatcong Valley Groundwater
Jan 14, 2015The Department of Justice and the U.S. Environmental Protection Agency (EPA) today announced a proposed settlement with several companies to address the Pohatcong Valley Groundwater Contamination Superfund site in Warren County, New Jersey. ...
-
Packaging and Waste Management Projects Do Not Always Aim to Improve Sustainability
Dec 9, 2014Packaging and waste management projects do not always begin with the impulse to improve sustainability. What the PCA demonstrates in its new resource, The Business Case for Packaging Sustainability is that there are benefits in considering ...
Tags: waste management, Packaging
-
Scientists at TSRI Have Developed a Method for Modifying Organic Molecules
Mar 12, 2014Scientists at The Scripps Research Institute (TSRI) have developed a method for modifying organic molecules that significantly expands the possibilities for developing new pharmaceuticals and improving old ones. "This is a technology that ...
-
BMS Received Breakthrough Therapy Designation for Its Investigational DCV Dual Regimen
Feb 26, 2014Bristol-Myers Squibb (BMS) has received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for its investigational DCV Dual Regimen (daclatasvir and asunaprevir) for use as a combination therapy in the treatment ...
Tags: Bristol-Myers, Medicine
-
U.S. Food and Drug Administration Will Investigate Possible Links
Feb 25, 2014TUESDAY Feb. 11, 2014, 2014 -- The U.S. Food and Drug Administration announced Tuesday that it will investigate possible links between the diabetes drug saxagliptin and a heightened risk for heart failure among users. In a statement, the ...
Tags: FDA, Diabetes Drug, Heart Failure, NEJM
-
Initiation of Secure Supply Chain Pilot Program to Enhance The Security of Imported Drugs
Feb 19, 2014The U.S. Food and Drug Administration is announcing the initiation of the Secure Supply Chain Pilot Program to enhance the security of imported drugs. In August 2013, the FDA published a notice in the Federal Register (78 FR 51192) to ...
-
DuPont Named AnnaMaria DeSalva Vice President of Corporate Communications
Feb 13, 2014DuPont named AnnaMaria DeSalva vice president of corporate communications. In the newly established role, DeSalva, will be responsible for leading, developing and executing the company's strategic communications and brand management around ...
Tags: DuPont, coating, corporate communications, DeSalva
-
Diabetes Alliance Is Providing a Three-Year Grant to The American Diabetes Pathway
Jan 16, 2014AstraZeneca (NYSE:AZN) and Bristol-Myers Squibb Company (NYSE:BMY) today announced that the companies' U.S. Diabetes Alliance is providing a three-year grant to the American Diabetes Association's Pathway to Stop Diabetes program. The ...
-
Farxiga Has Been Approved to Treat Adults with Type 2 Diabetes
Jan 13, 2014Farxiga (dapaglifozin) has been approved by the U.S. Food and Drug Administration to treat adults with type 2 diabetes, the agency said Wednesday in a news release. The drug, to be used for blood sugar control along with proper diet and ...
Tags: Farxiga, Type 2 Diabetes, Medicine News
-
Bristol-Myers Squibb Has Announced a Series of Related Changes
Jan 2, 2014Bristol-Myers Squibb has announced a series of related changes within its senior management team. To support its ongoing success as a BioPharma leader, the company is evolving its business model, creating a global integrated commercial ...
-
Adding Cancer Drug Dasatinib to Therapy May Slow Progression of Advanced Breast Cancer
Dec 26, 2013Adding the cancer drug dasatinib to standard hormone therapy may slow the progression of advanced breast cancer, a preliminary study suggests. The drug, sold under the name Sprycel, is already approved in the United States for chronic ...
Tags: cancer drug, dasatinib, hormone therapy, advanced breast cancer
-
Paediatric Formulation Development Is More Complex Than The Associated Adult Medicines
Dec 19, 2013A collaborative pharmaceutical project focused on improving the pathway for developing paediatric formulations has been given the go-ahead after successfully securing an innovation grant. The UK-wide consortium, led by Astra Zeneca, ...
-
Rainbow Coral and Its Joint Venture Partner Have Reached a Major New Milestone
Dec 16, 2013Rainbow Coral and its joint venture partner, Therakine, have reached a major new milestone in the development of a revolutionary new drug delivery technology. The companies reached terms to initiate Phase II of research and analysis on a ...
Tags: RBCC, Drug Delivery Development
-
EMA Has Issued Positive Opinion
Nov 26, 2013European Medicines Agency's (EMA) the Committee for Medicinal Products for Human Use (CHMP) has issued positive opinion for AstraZeneca and Bristol-Myers Squibb's of Xigduo for adults aged 18 and older with type 2 diabetes mellitus. The ...